Chris Waine's blog articles
- All
- Artificial Intelligence
- Biocompatibility
- Medical Devices
- Pharmaceutical
- Pharmacology
- Cosmetics
- Animal testing
- CE certification
- In Silico
- ISO 10993
- Pet food safety
- REACH
- Food-contact
- Multi-component product
- Extractables + Leachables
- Developmental Neurotoxicity
- In Vitro Test Battery
- Electronic Nicotine Delivery Systems (ENDS)
- E-liquid
- Ingredient screening
- Organophosphorus compound neurotoxicity
- Organophosphorus compounds
- OPIDN
- Literature searching
- TRACE
- Sensitisation
- NAMs
- BPA
NAMs for NGRAs
Blog articles
Traditionally, toxicological risk assessment has involved identifying a point of departure (PoD) such as a NOAEL or LOAEL in a study of small creatures, adjusting it to be relevant to humans (to derive, for example, a TI or DNEL), and then calculating the margin of safety to a measured or estimated external exposure. As part of this process, toxicologists have to account for the uncertainties that arise in moving from the species, route and duration of the laboratory animal study to the real human world.